NeuPath Health Inc. (NPTH.V)
| Previous Close | 0.1900 |
| Open | 0.1900 |
| Bid | 0.1900 x N/A |
| Ask | 0.1950 x N/A |
| Day's Range | 0.1900 - 0.1900 |
| 52 Week Range | 0.1300 - 0.2500 |
| Volume | |
| Avg. Volume | 55,519 |
| Market Cap | 10.696M |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
TORONTO, June 13, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held on June 12, 2024. All figures are in Canadian dollars, unless otherwise noted.
- Business Wire
NEUPATH HEALTH REPORTS RECORD QUARTERLY REVENUES WITH FIRST QUARTER 2024 RESULTS
TORONTO, May 16, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months ended March 31, 2024. All figures are in Canadian dollars, unless otherwise noted.
- Business Wire
NEUPATH HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
TORONTO, April 10, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference to be held April 16 to 17, 2024 at the Metro Toronto Convention Centre.
